Since the start of the year, in both Australia and France, clinical trial participants have died and over a dozen have been hospitalised after experiencing adverse reactions to drugs. To potential participants, these events are a costly reminder of the perilous risks involved in clinical trials. Initially hailed as revolutionary, cancer drug 'Zydelig' was approved in Australia during 2015. Earlier this month it was revealed that the drug has led to patient deaths and is now being investigated by authorities in both Australia and the United States. Clinical trials play an indispensable role in medical research. However, a potential participant must approach a trial cautiously - even where the drug appears to be widely approved. Before agreeing to participate in a trial, it is important to understand your rights and responsibilities under the contract in case the drug worsens your condition or causes death. If you or a loved one has suffered while participating in a clinical trial and would like information about your rights to compensation, call Adviceline Injury Lawyers on (03) 9321 9988.